A systematic review of eculizumab for atypical haemolytic uraemic syndrome (aHUS)

OBJECTIVE: To determine the efficacy and safety of eculizumab for patients with atypical haemolytic uraemic syndrome (aHUS), compared with current treatment options. DESIGN: A systematic review was performed according to the general principles of the Preferred Reporting Items for Systematic Reviews...

Descripción completa

Detalles Bibliográficos
Autores principales: Rathbone, John, Kaltenthaler, Eva, Richards, Anna, Tappenden, Paul, Bessey, Alice, Cantrell, Anna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2013
Materias:
Renal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3822313/
https://www.ncbi.nlm.nih.gov/pubmed/24189082
http://dx.doi.org/10.1136/bmjopen-2013-003573

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3822313/
https://www.ncbi.nlm.nih.gov/pubmed/24189082
http://dx.doi.org/10.1136/bmjopen-2013-003573

Ejemplares similares